Results 261 to 270 of about 105,790 (331)

Standardizing Protein Corona Characterization in Nanomedicine: A Multicenter Study to Enhance Reproducibility and Data Homogeneity [PDF]

Ali Akbar Ashkarran, Hassan Gharibi, Seyed Majed Modaresi, Amir Ata Saei, Morteza Mahmoudi   +4 more
openalex   +1 more source

Microglial Membranes Wrapped Ultrasmall Medium‐Entropy Ru Single‐Atom Nanozyme: Enhanced Catalysis for Accelerating Inflammation/Redox Microenvironment Regulation in Intracerebral Hemorrhage

Advanced Science, EarlyView.
PtRhIr/Ru SAN@M nanozymes cross the blood–brain barrier and selectively accumulate in hemorrhagic brain regions. By mimicking multiple enzyme activities, they attenuate oxidative stress, modulate microglial polarization toward an anti‐inflammatory phenotype, inhibit ferroptosis, and promote neuronal repair.
Jiebo Li, Penghui Wei, Yuanbo Pan, Hongjia Zheng, Jiajun Hu, Qianxi Chen, Zhongyuan Shen, Yongrui Hu, Jiajun Wu, Fuxin Lin, Fuxiang Chen, Chenyu Ding, Wenhua Fang, Yuanxiang Lin, Dezhi Kang, Yuxiang Gu, Yang Zhu, Dengliang Wang   +17 more
wiley   +1 more source

Targeted Degradation of eEF2K by a Structure‐Guided PROTAC Strategy for the Treatment of Triple‐Negative Breast Cancer

Advanced Science, EarlyView.
This study developed an eEF2K‐targeting PROTAC, A6, that efficiently degrades eEF2K in TNBC cells, inhibiting tumor growth in vitro and in vivo. To enhance tumor‐specific delivery, we engineered A6@ZIF‐8, a pH‐sensitive nanocarrier, which improved drug accumulation at tumor sites, offering a promising therapeutic strategy for TNBC through targeted ...
Shijun Cao, Changxin Zhong, Shilong Jiang, Yungui Li, Yang Xi, Mingxuan Xiao, Ting Jiang, Xiaoya Wan, Zonglin Chen, Xiaohui Yu, Yan Cheng   +10 more
wiley   +1 more source

Nanomaterials in Drug Delivery: Leveraging Artificial Intelligence and Big Data for Predictive Design. [PDF]

Int J Mol Sci
Han Y, Kim DH, Pack SP.
europepmc   +1 more source

Nanomedicine hitchhiking on bacteria for treating tumors [PDF]

Shujing Zheng, Xingwei Li, Shutao Guo
openalex   +1 more source

Overcoming PEG Antigenicity: Statistical PEG Isomers Reduce Antibody Binding

Advanced Science, EarlyView.
Conventional poly(ethylene glycol) (PEG) is commonly applied in biomedicine, but is now known to induce antibody formation. Here, it is shown that the development of “randomized PEG” (rPEG) featuring glycidyl methyl ether (GME) comonomers decreased antibody binding.
Mareike Deuker, Dominik Schulz, Kaloian Koynov, Svenja Morsbach, Holger Frey, Katharina Landfester   +5 more
wiley   +1 more source

Targeting Metal Ion Homeostasis for Regulated Cell Death-Amplified Tumor Nanomedicine. [PDF]

Int J Nanomedicine
Chen Q, Li K, Li J, Liu X, Li J, Xu L, Han Y, Zou T, Wang X, Yao Y, Mao Y.   +10 more
europepmc   +1 more source

New technology and clinical applications of nanomedicine: Highlights of the second annual meeting of the American Academy of Nanomedicine (Part I)

, 2006
Chiming Wei, Yuri L. Lyubchenko, Hamid Ghandehari, Justin Hanes, Kathleen J. Stebe, Hai‐Quan Mao, Donald T. Haynie, Donald A. Tomalia, Marianna Földvári, Nancy A. Monteiro‐Riviere, Petia P. Simeonova, Shuming Nie, Hidezo Mori, Susan P. Gilbert, David Needham   +14 more
openalex   +2 more sources

Antibody‐Empowered Nanomedicine for Precise Biomedical Applications

Advanced Science, EarlyView.
This review explores strategies for functionalizing nanoparticles with antibodies to construct antibody‐empowered nanomedicine. It discusses the classification of these nanomedicines based on antibody structure, with a specific focus on their biomedical applications in diagnostics, bioimaging, and therapeutics for various diseases.
Chen Chen, Xinglin Chen, Zhenhao Gao, Meng Sun, Yaozong Yu, Fang Lv, Qiujun Wang, Jinfeng Zhang   +7 more
wiley   +1 more source

Emerging nanomedicine for liver diseases treatment. [PDF]

J Nanobiotechnology
Zhu Y, Ge D, Wang J, Sun H, Li W, Ren H.
europepmc   +1 more source